touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Systemic mastocytosis: Making the right decisions at the right time (video 2)

    touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY

    Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.  

    The multidisciplinary team

    • Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA
    • Allergist/Immunologist: Dr. Theo Gülen, Karolinska University Hospital, Stockholm, Sweden
    • Hematologist: Dr. Tsewang Tashi, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA

      • This touchPODCAST is for HCPs outside of the UK.

      This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation. 

      This activity is jointly provided by USF Health and touchIME.

      touchIME is an EBAC® accredited provider.

      For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com

      17 min
    • Systemic mastocytosis: Making the right decisions at the right time (video 1)

      touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY

      Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.  

      The multidisciplinary team

      • Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA
      • Dermatologist: Dr. Lauren Madigan, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA

        • This touchPODCAST is for HCPs outside of the UK.

        This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation. 

        This activity is jointly provided by USF Health and touchIME.

        touchIME is an EBAC® accredited provider.

        For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com

        15 min
      • Immunotherapy in R/M NPC: Interpreting the evidence and individualizing care

        touchEXPERT FOCUS for touchONCOLOGY

        Listen to an interview with Dr. Deborah Wong as she shares her expert insights on the current evidence and latest guidelines for immune checkpoint inhibitor (ICIs) use in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). She also discusses how patient- and disease-specific factors can inform individualized treatment decisions.

        The expert:

        Dr. Deborah Wong, University of California, Los Angeles (UCLA), CA, USA

         

        This activity is funded by an independent medical education grant from Coherus Oncology, Inc.

        This activity is jointly provided by USF Health and touchIME.

        This touchPODCAST is for HCPs in the USA only.

         

        For further information, please visit our website: www.touchONCOLOGY.com

         

        21 min
      • Chronic and/or recurrent postoperative intraocular inflammation: Improving diagnosis, classification and management

        touchEXPERT FOCUS for touchOPHTHALMOLOGY

        Listen to a series of short interviews with three leading experts discussing chronic and/or recurrent postoperative intraocular inflammation. The faculty explore how to identify patients with persistent disease, differentiate infectious, mechanical, and non-infectious etiologies, and use multimodal imaging to evaluate underlying causes and posterior segment involvement. They also discuss how diagnostic findings guide treatment decisions, when to reassess or escalate management, and practical approaches to achieving durable disease control through individualized, etiology-driven treatment strategies.

        The experts:

        • Dr. Aniruddha Agarwal—Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
        • Prof. Marion Munk—Augenarzt-Praxisgemeinschaft Gutblick AG, Pfäffikon, Switzerland; University Hospital Bern, Switzerland; Northwestern University, Chicago, IL, USA
        • Prof. Francesco Bandello—University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy

          • This touchPODCAST is for healthcare professionals outside of the UK and USA.

          This activity is supported by an independent medical education grant from Alimera Sciences Europe Ltd.

          This activity is jointly provided by Partners for Advancing Clinical Education and touchIME. touchIME is an EBAC® accredited provider.

          For further information visit our website: touchophthalmologyime.org

          41 min
        • Advancing the management of HER2-altered NSCLC: Interpreting the latest clinical trial data

          touchCONGRESS for touchONCOLOGY and touchRESPIRATORY

           

          Listen to thoracic oncologist Dr. Julia Rotow (USA) review the latest HER2-targeted therapy data for NSCLC from the 2026 ASCO Annual Meeting. Alongside Prof. David Planchard (France) and Dr. Misako Nagasaka (USA), they discuss these findings in the context of evidence presented at recent international congresses and their clinical implications for managing HER2-altered NSCLC.

          The experts

          • Dr. Julia Rotow, Dana-Farber Cancer Institute, Boston, MA, USA
          • Prof. David Planchard, Institut Gustave Roussy, Paris, France
          • Dr. Misako Nagasaka, University of California, Irvine (UCI) Health Chao Family Comprehensive Cancer Center, Orange, CA, USA

            • This touchPODCAST is for HCPs outside of the UK.

            This activity is funded by an independent medical education grant from AstraZeneca. 

            This activity is jointly provided by USF Health and touchIME. 

            touchIME is an EBAC® accredited provider.

            For further information, visit our website: www.touchoncology.com or www.touchrespiratory.com

            50 min
          • Where we are now in PDAC care: Clinical insights, emerging biomarkers and evolving therapeutic strategies

            touchPANEL DISCUSSION for touchONCOLOGY

            Listen to a panel of leading experts discuss how biomarker-driven insights and emerging therapies are shaping treatment decisions in PDAC. They cover early testing strategies, novel targeted and immunologic therapies, and evidence-based treatment sequencing across the disease continuum.

            The experts:

            • Dr. Allyson Ocean - Weill Cornell Medicine, New York, NY, USA
            • Prof. Thierry Conroy - Institut de Cancérologie de Lorraine, University of Lorraine Nancy, France
            • Dr. Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States

              • This touchPODCAST is for HCPs outside of the UK.

              This activity is funded by an independent medical education grant from Revolution Medicines.

              The activity is jointly provided by USF Health and touchIME.

              touchIME is an EBAC® accredited provider.

              For further information visit our website: www.touchONCOLOGY.com

              45 min
            • Reimagining Alzheimer’s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives

              touchPANEL DISCUSSION for touchNEUROLOGY

              Listen to three leading experts discussing the recent advances in timely, biomarker-guided diagnosis and how current and emerging intravenous and subcutaneous disease-modifying therapies may impact clinical practice in the future and enable treatment personalization based on the underlying pathology of Alzheimer’s disease

              The experts

              • Dr Soo Borson, Keck USC School of Medicine, Los Angeles, CA, USA
              • Dr Clifford Singer, Northern Light Acadia Hospital, Bangor, ME, USA
              • Dr Frederick Ketchum, University of Wisconsin-Madison, Madison, WI, USA

                • This touchPODCAST is for HCPs outside of the UK only.

                This activity is funded by an independent medical education grant from Eisai Inc.

                Jointly provided by Partners for Advancing Clinical Education and touchIME in collaboration with the Gerontological Society of America (GSA).

                For further information, visit: 

                www.touchNEUROLOGY.com

                46 min
              • Building confidence in geographic atrophy care: From diagnosis to dialogue

                touchIN CONVERSATION for touchOPHTHALMOLOGY


                As treatment options for geographic atrophy continue to evolve, clinicians face new opportunities and challenges in diagnosis, treatment planning, and patient engagement. Join retina specialists Dr. Samuel Minaker and Dr. Priya Vakharia for a peer-to-peer discussion on geographic atrophy care, covering the patient journey from diagnosis to effective patient management and communication.

                The experts

                • Dr. Samuel Minaker, Tyler Retina Consultants, Tyler, TX, USA
                • Dr. Priya Vakharia, Retina Vitreous Associates of Florida, Tampa, FL, USA

                  • This touchPODCAST is for HCPs in the USA only.

                  This activity is supported by an independent medical education grant from Apellis, a Subsidiary of Biogen. 

                  Jointly provided by Partners for Advancing Clinical Education and touchIME.

                  For further information visit our website: www.touchOPHTHALMOLOGY.com

                  39 min
                • Beyond ATTR in Japan: Accurate diagnosis of cardiac AL in the TTR stabilizer era (in Japanese)

                  touchEXPERT FOCUS for touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY


                  Listen to a series of interviews with Dr. Toru Kubo as he shares his expert insights into real-world diagnostic pitfalls in cardiac amyloid light-chain amyloidosis (AL), stepwise application of the Japanese Circulation Society (JCS) diagnostic algorithm to achieve an accurate diagnosis of cardiac AL, and timely engagement of hematology and multidisciplinary discussion around transthyretin (TTR) stabilizer initiation.

                  The expert:

                  • Dr. Toru Kubo, Kochi Medical School, Kochi University, Japan

                    • This touchPODCAST is recorded in Japanese and is intended for HCPs in Japan.

                     

                    This activity is supported by an independent educational grant from Alexion Pharma GmbH.

                    Jointly provided by Partners for Advancing Clinical Education and TouchIME.


                    For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY

                    30 min
                  • Targeting pathogenic mechanisms in gMG: From complement- and FcRn-directed therapies to B- and T-cell-targeted approaches

                    touchTALKS for touchNEUROLOGY

                    Listen to an autoimmune neuromuscular disease expert review the unmet needs for patients with generalized myasthenia gravis and explain how emerging targeted therapies address underlying disease mechanisms to improve patient outcomes.

                    The expert

                    • Dr. Richard Nowak, Yale School of Medicine, New Haven, CT, USA

                      • This touchPODCAST is for healthcare professionals outside of the UK.

                      This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany.

                      This activity is jointly provided by USF Health and touchIME.

                      touchIME is an EBAC® accredited provider. 

                       

                      For further information, visit our website: https://touchneurologyime.org/targeted-therapies-in-gmg/

                       

                      41 min

                    About touchPODCAST

                    From the publisher's feed

                    Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.